Brief: Cspc Pharmaceutical Says CSPC Innovation Expects HY Net Profit Of 1.18 Billion-1.36 Billion Yuan
27/07/2026 15:56
BRIEF-Cspc Pharmaceutical Says CSPC Innovation Expects HY Net Profit Of 1.18 Billion-1.36 Billion Yuan July 27 (Reuters) - CSPC Pharmaceutical Group Ltd 1093.HK:
CSPC INNOVATION EXPECTS H1 NET PROFIT OF 1.18 BILLION-1.36 BILLION YUAN VERSUS LOSS YEAR AGO
Further company coverage: 1093.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSPC PHARMACEUTICAL
See all newsBrief: CSPC Pharmaceutical Posts CSPC Innovation Pharmaceutical 9M Net Profit Attributable RMB 1.21 Billion
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines